
This is a list of states, and some territories by the annual prevalence ofcocaine use, as percentage of the population aged 12–64, unless otherwise indicated, published by theUnited Nations Office on Drugs and Crime (UNODC).[1] The indicator is the "annual prevalence" rate which is the percentage of the youth and adult population who have consumed the drug at least once in the past year.
| Country or Entity | Prevalence (%) | Year | Notes |
|---|---|---|---|
| 2.7 | 2017 | (Age 15-64)[2] | |
| 2.67 | 2017 | (Age 16–59)[2] | |
| 2.5 | 2014 | (Age 15-64)[2] | |
| 2.5 | 2016 | (Age 14+)[2] | |
| 2.34 | 2014 | (Age 16–64)[2] | |
| 2.4 | 2022 | (Age 15–64)[3] | |
| 2.5 | 2021 | (Age 15–64)[3] | |
| 1.8 | 2014 | (Age 15–64)[2] | |
| 1.8 | 2017 | (Age 15-64)[2] | |
| 1.8 | 2014 | (Age 15–65)[2] | |
| 1.67 | 2017 | (Age 15–64)[2] | |
| 1.5 | 2021 | (Age 15–64)[3] | |
| 1.6 | 2017 | (Age 15–64)[3] | |
| 2.3 | 2019 | (Age 15–64)[3] | |
| 1.47 | 2015 | (Age 15–64)[2] | |
| 0.3 | 2018 | (Age 15–64)[3] | |
| 1.38 | 2016 | (Age 15–64)[2] | |
| 1.33 | 2015 | (Age 15–64)[2] | |
| 1.3 | 2009 | (Age 16–65)[2] | |
| 1.21 | 2017 | (Age 15–64)[2] | |
| 1.5 | 2021 | (Age 15–64)[3] | |
| 1.06 | 2015 | (Age 15–64)[2] | |
| 1.02 | 2011 | (Age 15–64)[2] | |
| 1 | 2016 | (Age 15–64)[2] | |
| 0.98 | 2010 | (Age 15–64)[2] | |
| 0.9 | 2003 | [4] (UNODC estimates) | |
| 0.88 | 2010 | (Age 15–64)[2] | |
| 0.87 | 2005 | (Age 12–35)[2] | |
| 0.85 | 2005 | (Age 12–65)[2] BBC | |
| 0.81 | 2016 | (Age 15–64)[2] | |
| 1.8 | 2019 | (Age 15–64)[3] | |
| 0.8 | 2016 | (Age 12–65)[2] | |
| 0.7 | 2013 | (Age 12–65)[2] | |
| 0.7 | 2002 | [4] (UNODC estimates) | |
| 0.7 | 2002 | [4] (UNODC estimates) | |
| 0.7 | 2010 | (Age 12–65)[2] | |
| 0.69 | 2006 | (Age 12–65)[2] | |
| 0.64 | 2011 | (Age 12–65)[2] | |
| 0.63 | 2008 | (Age 15–64)[2] | |
| 0.6 | 2000 | [4] (UNODC estimates) | |
| 0.6 | 2016 | (Age 18–65)[2] | |
| 1 | 2018 | (Age 15–64)[3] | |
| 1.6 | 2021 | (Age 15–64)[3] | |
| 0.6 | 2008 | (Age 16–64; cocaine/crack)[2] | |
| 0.6 | 2010 | (Age 15–64)[2] | |
| 1.3 | 2021 | (Age 15–64)[3] | |
| 1.4 | 2018 | (Age 15–64)[3] | |
| 0.9 | 2018 | (Age 15–64)[3] | |
| 1.3 | 2020 | (Age 15–64)[3] | |
| 0.5 | 2013 | (Age 15–64)[2] | |
| 0.8 | 2018 | (Age 15–64)[3] | |
| 0.48 | 2010 | (Age 15–64)[2] | |
| 1.5 | 2022 | (Age 15–64)[3] | |
| 0.4 | 2006 | (Age 15–64)[2] | |
| 0.4 | 2015 | (Age 15–64)[3] | |
| 0.4 | 2003 | [4] (UNODC estimates) | |
| 0.4 | 1998 | [4] | |
| 0.5 | 2019 | (Age 15–64)[3] | |
| 0.37 | 2014 | (Age 12–65)[2] | |
| 0.36 | 2014 | (Age 12–65)[2] | |
| 0.34 | 2015 | (Age 15–64)[2] | |
| 0.32 | 2010 | (Age 12–65)[2] | |
| 0.32 | 2015 | (Age 15–64)[2] | |
| 0.3 | 2019 | (Age 15–64)[3] | |
| 0.6 | 2020 | (Age 15–64)[3] | |
| 0.9 | 2020 | (Age 15–64)[3] | |
| 0.25 | 2008 | (Age 15–64)[2] | |
| 0.25 | 2003 | (Age 12–64)[2] | |
| 0.25 | 2013 | (Age 12–65)[2] | |
| 0.23 | 2007 | (Age 15–64)[2] | |
| 0.21 | 2005 | (Age 15–64)[2] | |
| 0.2 | 2012 | (Age 15–64)[2] | |
| 0.2 | 2017 | (Age 15–64)[2] | |
| 0.5 | 2019 | (Age 15–64)[3] | |
| 0.1 | 2019 | (Age 15–64)[3] | |
| 0.2 | 2000 | [4] (Tentative estimates) | |
| 0.2 | 1998 | [4] | |
| 0.2 | 2016 | (Age 15–64)[2] | |
| 0.1 | 2005 | (Age 15–64)[2] | |
| 0.1 | 2018 | (Age 10–75)[2] | |
| 0.1 | 2001 | [4] (UNODC estimates) | |
| 0.6 | 2021 | (Age 15–64)[3] | |
| 0.1 | 2000 | [4] | |
| 0.1 | 2014 | (Age 18–64)[2] | |
| 0.1 | 2005 | (Age 15–64)[2] | |
| 0.1 | 2016 | (Age 15–64)[2] | |
| 0.1 | 2015 | (Age 12–65)[2] | |
| 0.08 | 2013 | (Age 12–65)[2] | |
| 0.07 | 2016 | (Age 10–69)[2] | |
| 0.06 | 2007 | (Age 15–64)[2] | |
| 0.05 | 2004 | (Age 15–64)[2] | |
| 0.05 | 2007 | (Age 15–64)[2] | |
| 0.05 | 2017 | (Age 15–64)[2] | |
| 0.04 | 2012 | (Age 15–64)[2] | |
| 0.04 | 2005 | (Age 15–64)[2] | |
| 0.04 | 2008 | (Age 15–64)[2] | |
| 0.03 | 2004 | (Age 15–64)[2] | |
| 0.03 | 2017 | (Age 15–64)[2] | |
| 0.02 | 2006 | (Age 15–64)[2] | |
| 0.02 | 1997 | [4] | |
| 0.02 | 1996 | [4] | |
| 0.01 | 2010 | (Age 12+)[2] | |
| 0.01 | 1999 | [4] | |
| 0.0 | 2015 | (Age 10–60)[2] | |
| 0.01 | 1995 | [4] | |
| 0.093 | 2017 | (Age 15–64)[2] | |
| 0.01 | 2008 | (Age 15–64)[2] | |
| 0.001 | 2009 | (Age 15–64)[2] | |
| 0.001 | 2005 | (Age 15–64)[2] | |
| 0.0002 | 2004 | [4] |

Zuid, Antwerp in Belgium has the highest reported level, with 2,381 milligrams per 1,000 people daily. Following this,Tarragona, Spain has 1,611 milligrams, andHalifax, Canada shows 1,326 milligrams. Other notable cities includeMontreal, Canada at 1,227 milligrams;Amsterdam, Netherlands at 1,142 milligrams; andEdmonton, Canada at 1,039 milligrams.[5]
MetroVancouver, Canada reports 991 milligrams, andBrussels, Belgium has 985 milligrams.Toronto, Canada has 890 milligrams, whileGeneva, Switzerland reports 770 milligrams. Other cities with lower measurements includeValencia,Eindhoven, andPrague, showing a range from 724 to 513 milligrams per 1,000 people.[5]